Industries > Pharma > Parenteral Nutrition Market Report 2021-2031
Parenteral Nutrition Market Report 2021-2031
By Nutrition Type (Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solutions, Trace Elements, Electrolytes, & Minerals, Vitamins, and Others), By Type (Generic, and Branded), Patient Demographics (Adults, Geriatric, and Pediatric), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Leading Regional/ Country market analysis
Parenteral Nutrition Market– our new study reveals trends, R&D progress, and predicted revenues
Where the Parenteral Nutrition is market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 240+ page report provides 380+ tables and 360+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Parenteral Nutrition Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
• Revenue and growth forecasts from 2021 to 2031 for the Global Parenteral Nutrition Market By Nutrition Type
• Carbohydrates
• Parenteral Lipid Emulsions
• Single Dose Amino Acid Solutions
• Trace Elements, Electrolytes, & Minerals
• Vitamins
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Parenteral Nutrition Market By Type
• Generic
• Branded
• Revenue and growth forecasts from 2021 to 2031 for the Global Parenteral Nutrition Market By Patient Demographics
• Adults
• Geriatric
• Pediatric
• Revenue and growth forecasts from 2021 to 2031 for the Global Parenteral Nutrition Market By End User
• Hospitals
• Homecare
• Specialty Clinics
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Parenteral Nutrition Market By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Parenteral Nutrition Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Parenteral Nutrition Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Parenteral Nutrition Market report helps you
In summary, our 240+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Parenteral Nutrition Market, with forecasts for Get our report today Parenteral Nutrition Market Forecast 2021-2031: By Nutrition Type, Type, Patient Demographics End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Parenteral Nutrition market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Parenteral Nutrition Market. Some of the company’s profiled in this report include
• B. Braun Melsungen AG
• Fresenius Kabi AG
• ALLERGAN
• Grifols, S.A.
• Pfizer Inc.
• Otsuka Pharmaceutical Factory, Inc
• Baxter
• Vifor Pharma
• Aculife
• Grifols, S.A.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Parenteral Nutrition Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Parenteral Nutrition Market Report 2021-2031: By Nutrition Type (Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solutions, Trace Elements, Electrolytes, & Minerals, Vitamins, and Others), By Type (Generic, and Branded), Patient Demographics (Adults, Geriatric, and Pediatric), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Leading Regional/ Country market analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Parenteral Nutrition Market
2.1. Parenteral Nutrition Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Parenteral Nutrition Market Overview
3.1. Global Parenteral Nutrition Market Size and Forecast By Region
3.2. Global Parenteral Nutrition Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing prevalence of chronic diseases around the world
3.3.1.2. Increasing research and development for parenteral nutrition
3.3.1.3. Increasing strategic initiatives in parenteral nutrition market
3.3.1.4. Rapidly changing lifestyle
3.3.1.5. Increasing awareness in emerging nations
3.3.2. Market Restraints
3.3.2.1. Stringent regulation associated with product development
3.3.2.2. High cost of development
3.3.3. Opportunities
3.3.3.1. Increasing therapeutic advancements in parenteral nutrition
3.3.3.2. Growing awareness regarding consumption of parenteral nutrition
3.3.4. Challenges
3.3.4.1. Availability of alternatives
3.3.4.2. Increasing competitors in the market
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Parenteral Nutrition Market Analysis and Forecast 2021-2031, By Nutrition Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Carbohydrates
4.1.1.1. Carbohydrates market size and forecast, 2021-2031 (USD Million)
4.1.2. Parenteral Lipid Emulsions
4.1.2.1. Parenteral Lipid Emulsions market size and forecast, 2021-2031 (USD Million)
4.1.3. Single Dose Amino Acid Solutions
4.1.3.1. Single Dose Amino Acid Solutions market size and forecast, 2021-2031 (USD Million)
4.1.4. Trace Elements, Electrolytes, & Minerals
4.1.4.1. Trace Elements, Electrolytes, & Minerals Market size and forecast, 2021-2031 (USD Million)
4.1.5. Vitamins
4.1.5.1. Vitamins market size and forecast, 2021-2031 (USD Million)
4.1.6. Others
4.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Parenteral Nutrition Market Analysis and Forecast, 2021-2031 By Patient Demographics (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Geriatric
5.1.1.1. Geriatric market size and forecast, 2021-2031 (USD Million)
5.1.2. Adults
5.1.2.1. Adults market size and forecast, 2021-2031 (USD Million)
5.1.3. Pediatric
5.1.3.1. Pediatric market size and forecast, 2021-2031 (USD Million)
6. Global Parenteral Nutrition Market Analysis and Forecast, 2021-2031 By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Generic
6.1.1.1. Generic market size and forecast, 2021-2031 (USD Million)
6.1.2. Branded
6.1.2.1. Branded market size and forecast, 2021-2031 (USD Million)
7. Global Parenteral Nutrition Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Hospitals
7.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
7.1.2. Homecare
7.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
7.1.3. Specialty Clinics
7.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
7.1.4. Others
7.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Parenteral Nutrition Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Hospitals Pharmacy
8.1.1.1. Hospitals Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Pharmacy
8.1.2.1. Retail Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.3. Online Pharmacies
8.1.3.1. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
9. North America Parenteral Nutrition Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Parenteral Nutrition Market Size and Forecast By Nutrition Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Parenteral Nutrition Market Size and Forecast By Type
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Parenteral Nutrition Market Size and Forecast By Patient Demographics
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Parenteral Nutrition Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Parenteral Nutrition Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Parenteral Nutrition Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Parenteral Nutrition Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Parenteral Nutrition Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Parenteral Nutrition Market Size and Forecast By Nutrition Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Parenteral Nutrition Market Size and Forecast By Patient Demographics
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Parenteral Nutrition Market Size and Forecast By Type
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Parenteral Nutrition Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Parenteral Nutrition Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Parenteral Nutrition Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Parenteral Nutrition Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Parenteral Nutrition Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Parenteral Nutrition Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Parenteral Nutrition Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Parenteral Nutrition Market Size and Forecast By Nutrition Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Parenteral Nutrition Market Size and Forecast By Patient Demographics
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Parenteral Nutrition Market Size and Forecast By Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Parenteral Nutrition Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Parenteral Nutrition Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Parenteral Nutrition Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Parenteral Nutrition Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Parenteral Nutrition Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Parenteral Nutrition Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Parenteral Nutrition Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Parenteral Nutrition Market Size and Forecast By Nutrition Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Parenteral Nutrition Market Size and Forecast By Patient Demographics
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Parenteral Nutrition Market Size and Forecast By Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Parenteral Nutrition Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Parenteral Nutrition Market Size and Forecast By Distribution Channel
12.7. Brazil Parenteral Nutrition Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Parenteral Nutrition Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Parenteral Nutrition Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Parenteral Nutrition Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Parenteral Nutrition Market Size and Forecast By Nutrition Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Parenteral Nutrition Market Size and Forecast By Patient Demographics
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Parenteral Nutrition Market Size and Forecast By Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Parenteral Nutrition Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Parenteral Nutrition Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Parenteral Nutrition Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Parenteral Nutrition Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Parenteral Nutrition Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Parenteral Nutrition Market
14.1. B. Braun Melsungen AG
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Fresenius Kabi AG
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. ALLERGAN
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. Grifols, S.A.
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. Pfizer Inc.
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Otsuka Pharmaceutical Factory, Inc
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Baxter
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. Vifor Pharma
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Aculife
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. Pharming Healthcare, Inc.
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Parenteral Nutrition Market Drivers & Restraints 2021
Table 7. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 168. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Leading 10 Parenteral Nutrition Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 367. B. Braun Melsungen AGProfile 2019 (CEO, HQ, Founded, Website)
Table 368. B. Braun Melsungen AG Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 369. Fresenius Kabi AG Profile 2019 (CEO, HQ, Founded, Website)
Table 370. Fresenius Kabi AG Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 371. ALLERGAN Profile 2019 (CEO, HQ, Founded, Website)
Table 372. ALLERGAN.Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 373. Grifols, S.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 374. Grifols, S.A. Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 375. Pfizer Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 376. Pfizer Inc. Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 377. Otsuka Pharmaceutical Factory, Inc Profile 2019 (CEO, HQ, Founded, Website)
Table 378. Otsuka Pharmaceutical Factory, Inc Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 379. Baxter Profile 2019 (CEO, HQ, Founded, Website)
Table 380. Baxter Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 381. Vifor Pharma Profile 2019 (CEO, HQ, Founded, Website)
Table 382. Vifor Pharma Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 383. Aculife Profile 2019 (CEO, HQ, Founded, Website)
Table 384. Aculife Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 385. Pharming Healthcare, Inc. Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 386. Pharming Healthcare, Inc. Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 387. Other Companies Involved in the Parenteral Nutrition Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Parenteral Nutrition Market Drivers & Restraints 2021
Figure 7. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 123. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 128. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 133. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 138. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 143. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 148. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 153. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 158. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 168. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 198. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 199. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 200. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 201. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 202. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 203. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 204. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 205. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 206. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 207. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 208. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 209. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 210. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 211. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 212. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Porter’s Five Force Analysis
Companies Mentioned
1. AbbVie
2. Achaogen
3. Actavis
4. Actelion
5. Affinium Pharmaceutical
6. AiCuris GmbH & Co. KG
7. Alcon
8. Alkem Laboratories
9. Allergan
10. Allied Pharma
11. Apotex
12. APP Pharmaceuticals
13. Aptalis Pharma
14. Aquapharm Biodiscovery
15. Cempra Pharmaceuticals
16. Cipla
17. Claris Lifesciences
18. Cornerstone Biopharma
19. Cornerstone Therapeutics
20. Corona Remedies
21. Eli Lilly
22. Gate Pharma
23. Gilead Sciences
24. GlaxoSmithKline (GSK)
25. Glenmark
26. GlycoVaxyn
27. Hetero
28. Hikma Farmaceutica
29. Hi-Tech Pharma
30. Hospira
31. Macleod Pharmaceuticals
32. Microlabs
33. Nalneva
34. Novartis
35. Novexel
36. Paratek Pharmaceuticals
37. Pfizer
38. Ranbaxy
39. Roche
40. Sagent Pharmaceuticals
41. Sandoz
42. Sanofi
43. Sequella
44. Shanghai MengKe Pharmaceuticals
45. Shionogi
46. SHIONOGI Co., Ltd.
47. Shire
48. Sidmak Labs
49. Solitaire Pharmacia
50. Specialised Therapeutics Australia
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Parenteral Nutrition Market
2.1. Parenteral Nutrition Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Parenteral Nutrition Market Overview
3.1. Global Parenteral Nutrition Market Size and Forecast By Region
3.2. Global Parenteral Nutrition Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing prevalence of chronic diseases around the world
3.3.1.2. Increasing research and development for parenteral nutrition
3.3.1.3. Increasing strategic initiatives in parenteral nutrition market
3.3.1.4. Rapidly changing lifestyle
3.3.1.5. Increasing awareness in emerging nations
3.3.2. Market Restraints
3.3.2.1. Stringent regulation associated with product development
3.3.2.2. High cost of development
3.3.3. Opportunities
3.3.3.1. Increasing therapeutic advancements in parenteral nutrition
3.3.3.2. Growing awareness regarding consumption of parenteral nutrition
3.3.4. Challenges
3.3.4.1. Availability of alternatives
3.3.4.2. Increasing competitors in the market
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Parenteral Nutrition Market Analysis and Forecast 2021-2031, By Nutrition Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Carbohydrates
4.1.1.1. Carbohydrates market size and forecast, 2021-2031 (USD Million)
4.1.2. Parenteral Lipid Emulsions
4.1.2.1. Parenteral Lipid Emulsions market size and forecast, 2021-2031 (USD Million)
4.1.3. Single Dose Amino Acid Solutions
4.1.3.1. Single Dose Amino Acid Solutions market size and forecast, 2021-2031 (USD Million)
4.1.4. Trace Elements, Electrolytes, & Minerals
4.1.4.1. Trace Elements, Electrolytes, & Minerals Market size and forecast, 2021-2031 (USD Million)
4.1.5. Vitamins
4.1.5.1. Vitamins market size and forecast, 2021-2031 (USD Million)
4.1.6. Others
4.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Parenteral Nutrition Market Analysis and Forecast, 2021-2031 By Patient Demographics (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Geriatric
5.1.1.1. Geriatric market size and forecast, 2021-2031 (USD Million)
5.1.2. Adults
5.1.2.1. Adults market size and forecast, 2021-2031 (USD Million)
5.1.3. Pediatric
5.1.3.1. Pediatric market size and forecast, 2021-2031 (USD Million)
6. Global Parenteral Nutrition Market Analysis and Forecast, 2021-2031 By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Generic
6.1.1.1. Generic market size and forecast, 2021-2031 (USD Million)
6.1.2. Branded
6.1.2.1. Branded market size and forecast, 2021-2031 (USD Million)
7. Global Parenteral Nutrition Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Hospitals
7.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
7.1.2. Homecare
7.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
7.1.3. Specialty Clinics
7.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
7.1.4. Others
7.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Parenteral Nutrition Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Hospitals Pharmacy
8.1.1.1. Hospitals Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Pharmacy
8.1.2.1. Retail Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.3. Online Pharmacies
8.1.3.1. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
9. North America Parenteral Nutrition Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Parenteral Nutrition Market Size and Forecast By Nutrition Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Parenteral Nutrition Market Size and Forecast By Type
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Parenteral Nutrition Market Size and Forecast By Patient Demographics
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Parenteral Nutrition Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Parenteral Nutrition Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Parenteral Nutrition Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Parenteral Nutrition Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Parenteral Nutrition Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Parenteral Nutrition Market Size and Forecast By Nutrition Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Parenteral Nutrition Market Size and Forecast By Patient Demographics
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Parenteral Nutrition Market Size and Forecast By Type
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Parenteral Nutrition Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Parenteral Nutrition Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Parenteral Nutrition Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Parenteral Nutrition Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Parenteral Nutrition Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Parenteral Nutrition Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Parenteral Nutrition Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Parenteral Nutrition Market Size and Forecast By Nutrition Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Parenteral Nutrition Market Size and Forecast By Patient Demographics
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Parenteral Nutrition Market Size and Forecast By Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Parenteral Nutrition Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Parenteral Nutrition Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Parenteral Nutrition Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Parenteral Nutrition Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Parenteral Nutrition Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Parenteral Nutrition Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Parenteral Nutrition Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Parenteral Nutrition Market Size and Forecast By Nutrition Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Parenteral Nutrition Market Size and Forecast By Patient Demographics
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Parenteral Nutrition Market Size and Forecast By Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Parenteral Nutrition Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Parenteral Nutrition Market Size and Forecast By Distribution Channel
12.7. Brazil Parenteral Nutrition Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Parenteral Nutrition Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Parenteral Nutrition Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Parenteral Nutrition Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Parenteral Nutrition Market Size and Forecast By Nutrition Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Parenteral Nutrition Market Size and Forecast By Patient Demographics
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Parenteral Nutrition Market Size and Forecast By Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Parenteral Nutrition Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Parenteral Nutrition Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Parenteral Nutrition Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Parenteral Nutrition Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Parenteral Nutrition Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Parenteral Nutrition Market
14.1. B. Braun Melsungen AG
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Fresenius Kabi AG
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. ALLERGAN
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. Grifols, S.A.
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. Pfizer Inc.
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Otsuka Pharmaceutical Factory, Inc
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Baxter
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. Vifor Pharma
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Aculife
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. Pharming Healthcare, Inc.
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Parenteral Nutrition Market Drivers & Restraints 2021
Table 7. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 168. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Leading 10 Parenteral Nutrition Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 367. B. Braun Melsungen AGProfile 2019 (CEO, HQ, Founded, Website)
Table 368. B. Braun Melsungen AG Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 369. Fresenius Kabi AG Profile 2019 (CEO, HQ, Founded, Website)
Table 370. Fresenius Kabi AG Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 371. ALLERGAN Profile 2019 (CEO, HQ, Founded, Website)
Table 372. ALLERGAN.Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 373. Grifols, S.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 374. Grifols, S.A. Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 375. Pfizer Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 376. Pfizer Inc. Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 377. Otsuka Pharmaceutical Factory, Inc Profile 2019 (CEO, HQ, Founded, Website)
Table 378. Otsuka Pharmaceutical Factory, Inc Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 379. Baxter Profile 2019 (CEO, HQ, Founded, Website)
Table 380. Baxter Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 381. Vifor Pharma Profile 2019 (CEO, HQ, Founded, Website)
Table 382. Vifor Pharma Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 383. Aculife Profile 2019 (CEO, HQ, Founded, Website)
Table 384. Aculife Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 385. Pharming Healthcare, Inc. Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 386. Pharming Healthcare, Inc. Parenteral Nutrition Product Offering (Segment, Product Offerings)
Table 387. Other Companies Involved in the Parenteral Nutrition Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Parenteral Nutrition Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Parenteral Nutrition Market Drivers & Restraints 2021
Figure 7. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Carbohydrates Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Parenteral Lipid Emulsions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Single Dose Amino Acid Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Trace Elements, Electrolytes, & Minerals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Vitamins Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Parenteral Nutrition Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 123. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. North America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 128. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. North America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 133. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. North America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 138. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. North America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 143. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. North America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 148. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. North America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 153. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. North America Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 158. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. US Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. Canada Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 168. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. Europe Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Europe Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. Europe Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. Europe Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. Europe Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. Europe Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 198. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 199. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 200. Europe Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 201. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 202. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 203. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 204. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 205. UK Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 206. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 207. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 208. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 209. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 210. Germany Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 211. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 212. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. France Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. Rest of Europe Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Asia Pacific Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. Asia Pacific Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Asia Pacific Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. Asia Pacific Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Asia Pacific Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. Asia Pacific Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Asia Pacific Parenteral Nutrition Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. China Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. India Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. Japan Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. RoAPAC Parenteral Nutrition Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Middle East Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Middle East Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Middle East Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Middle East Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Middle East Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Middle East Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Latin America Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Latin America Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Latin America Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Latin America Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Latin America Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Latin America Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Africa Parenteral Nutrition Market Forecast By Nutrition Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Africa Parenteral Nutrition Market Forecast By Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Africa Parenteral Nutrition Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Africa Parenteral Nutrition Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Africa Parenteral Nutrition Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Africa Parenteral Nutrition Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Porter’s Five Force Analysis
Companies Mentioned
1. AbbVie
2. Achaogen
3. Actavis
4. Actelion
5. Affinium Pharmaceutical
6. AiCuris GmbH & Co. KG
7. Alcon
8. Alkem Laboratories
9. Allergan
10. Allied Pharma
11. Apotex
12. APP Pharmaceuticals
13. Aptalis Pharma
14. Aquapharm Biodiscovery
15. Cempra Pharmaceuticals
16. Cipla
17. Claris Lifesciences
18. Cornerstone Biopharma
19. Cornerstone Therapeutics
20. Corona Remedies
21. Eli Lilly
22. Gate Pharma
23. Gilead Sciences
24. GlaxoSmithKline (GSK)
25. Glenmark
26. GlycoVaxyn
27. Hetero
28. Hikma Farmaceutica
29. Hi-Tech Pharma
30. Hospira
31. Macleod Pharmaceuticals
32. Microlabs
33. Nalneva
34. Novartis
35. Novexel
36. Paratek Pharmaceuticals
37. Pfizer
38. Ranbaxy
39. Roche
40. Sagent Pharmaceuticals
41. Sandoz
42. Sanofi
43. Sequella
44. Shanghai MengKe Pharmaceuticals
45. Shionogi
46. SHIONOGI Co., Ltd.
47. Shire
48. Sidmak Labs
49. Solitaire Pharmacia
50. Specialised Therapeutics Australia
Companies Profiled in the Report
1. B. Braun Melsungen AG
2. Fresenius Kabi AG
3. ALLERGAN
4. Grifols, S.A.
5. Pfizer Inc.
6. Otsuka Pharmaceutical Factory, Inc
7. Baxter
8. Vifor Pharma
9. Aculife
10. Grifols, S.A.
List of Companies Mentioned in the Report:
1. AbbVie
2. Achaogen
3. Actavis
4. Actelion
5. Affinium Pharmaceutical
6. AiCuris GmbH & Co. KG
7. Alcon
8. Alkem Laboratories
9. Allergan
10. Allied Pharma
11. Apotex
12. APP Pharmaceuticals
13. Aptalis Pharma
14. Aquapharm Biodiscovery
15. Cempra Pharmaceuticals
16. Cipla
17. Claris Lifesciences
18. Cornerstone Biopharma
19. Cornerstone Therapeutics
20. Corona Remedies
21. Eli Lilly
22. Gate Pharma
23. Gilead Sciences
24. GlaxoSmithKline (GSK)
25. Glenmark
26. GlycoVaxyn
27. Hetero
28. Hikma Farmaceutica
29. Hi-Tech Pharma
30. Hospira
31. Macleod Pharmaceuticals
32. Microlabs
33. Nalneva
34. Novartis
35. Novexel
36. Paratek Pharmaceuticals
37. Pfizer
38. Ranbaxy
39. Roche
40. Sagent Pharmaceuticals
41. Sandoz
42. Sanofi
43. Sequella
44. Shanghai MengKe Pharmaceuticals
45. Shionogi
46. SHIONOGI Co., Ltd.
47. Shire
48. Sidmak Labs
49. Solitaire Pharmacia
50. Specialised Therapeutics Australia
List of Organizations Mentioned in the Report:
1. Centre for Pharmaceutical Administration Health Sciences Authority
2. Central Drug Standard Control Organization (CDSCO)
3. Organisation for Economic Co-operation and Development (OECD)
4. European Medicines Agency (EMA)
5. Food and Drug Administration (FDA)
6. National Institutes of Health (NIH)
7. United Nations (UN)
8. United Nations Office on Drugs and Crime (UNODC)
9. United Nations Statistics Division (UNSD)
10. Statistical Office of the European Union (EUROSTAT)
11. University of Connecticut
12. World Health Organization (WHO)
13. The National Medical Products Administration (NMPA)
14. Indian Council of Medical Research (ICMR)
15. The Therapeutic Goods Administration
16. The Federal Institute for Drugs and Medical Devices (BfArM)
17. Pharmaceuticals and Medical Devices Agency (PMDA)
18. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
19. Ministry of Health, Labour & Welfare(MHLW)
20. Medicines and Healthcare Products Regulatory Agency (MHRA)
1. B. Braun Melsungen AG
2. Fresenius Kabi AG
3. ALLERGAN
4. Grifols, S.A.
5. Pfizer Inc.
6. Otsuka Pharmaceutical Factory, Inc
7. Baxter
8. Vifor Pharma
9. Aculife
10. Grifols, S.A.
List of Companies Mentioned in the Report:
1. AbbVie
2. Achaogen
3. Actavis
4. Actelion
5. Affinium Pharmaceutical
6. AiCuris GmbH & Co. KG
7. Alcon
8. Alkem Laboratories
9. Allergan
10. Allied Pharma
11. Apotex
12. APP Pharmaceuticals
13. Aptalis Pharma
14. Aquapharm Biodiscovery
15. Cempra Pharmaceuticals
16. Cipla
17. Claris Lifesciences
18. Cornerstone Biopharma
19. Cornerstone Therapeutics
20. Corona Remedies
21. Eli Lilly
22. Gate Pharma
23. Gilead Sciences
24. GlaxoSmithKline (GSK)
25. Glenmark
26. GlycoVaxyn
27. Hetero
28. Hikma Farmaceutica
29. Hi-Tech Pharma
30. Hospira
31. Macleod Pharmaceuticals
32. Microlabs
33. Nalneva
34. Novartis
35. Novexel
36. Paratek Pharmaceuticals
37. Pfizer
38. Ranbaxy
39. Roche
40. Sagent Pharmaceuticals
41. Sandoz
42. Sanofi
43. Sequella
44. Shanghai MengKe Pharmaceuticals
45. Shionogi
46. SHIONOGI Co., Ltd.
47. Shire
48. Sidmak Labs
49. Solitaire Pharmacia
50. Specialised Therapeutics Australia
List of Organizations Mentioned in the Report:
1. Centre for Pharmaceutical Administration Health Sciences Authority
2. Central Drug Standard Control Organization (CDSCO)
3. Organisation for Economic Co-operation and Development (OECD)
4. European Medicines Agency (EMA)
5. Food and Drug Administration (FDA)
6. National Institutes of Health (NIH)
7. United Nations (UN)
8. United Nations Office on Drugs and Crime (UNODC)
9. United Nations Statistics Division (UNSD)
10. Statistical Office of the European Union (EUROSTAT)
11. University of Connecticut
12. World Health Organization (WHO)
13. The National Medical Products Administration (NMPA)
14. Indian Council of Medical Research (ICMR)
15. The Therapeutic Goods Administration
16. The Federal Institute for Drugs and Medical Devices (BfArM)
17. Pharmaceuticals and Medical Devices Agency (PMDA)
18. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
19. Ministry of Health, Labour & Welfare(MHLW)
20. Medicines and Healthcare Products Regulatory Agency (MHRA)
Download sample pages
Complete the form below to download your free sample pages for Parenteral Nutrition Market Report 2021-2031Download sample pages
Complete the form below to download your free sample pages for Parenteral Nutrition Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033
The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033
31 May 2023
Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
26 May 2023
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023
